US2020078383A1PendingUtilityA1
Use of agarobiose or agarooligosaccharide having anticariogenic activity
Assignee: UNIV KOREA RES & BUS FOUNDPriority: Nov 15, 2016Filed: Nov 15, 2017Published: Mar 12, 2020
Est. expiryNov 15, 2036(~10.3 yrs left)· nominal 20-yr term from priority
A23L 33/26A23L 33/125A61K 31/729A61P 31/04A61P 1/02A61K 31/7016A61K 8/73A61K 31/702A23V 2002/00A61Q 11/00A23L 33/10A23V 2200/312A61K 9/0056A23V 2250/5024A61K 8/60
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a use of an agarobiose or agarooligosaccharides having anticariogenic activity. More specifically, a lower concentration of agarobiose or agarooligosaccharides than the concentration of xylitol suppresses the growth of Streptococcus mutans and suppresses acid production, and thus can be used for anti-cariogenic purposes.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A pharmaceutical composition for preventing or treating an oral disease, comprising one or more selected from the group consisting of agarobiose and agarooligosaccharides,
wherein the oral disease is any one selected from the group consisting of dental caries, gingivitis, periodontitis, oral mucous ulcers, halitosis, and xerostomia.
2 . The pharmaceutical composition of claim 1 , wherein the agarooligosaccharides are obtained from an acid hydrolysate of agarose.
3 . The pharmaceutical composition of claim 1 , wherein the agarooligosaccharides are a mixture of agarobiose, agarotetraose, agarohexaose, and agarooctaose.
4 . The pharmaceutical composition of claim 1 , wherein the agarobiose is obtained by separating and purifying an acid hydrolysate of agarose through gel permeation chromatography.
5 . An oral hygiene composition for preventing or alleviating an oral disease, comprising one or more selected from the group consisting of agarobiose and agarooligosaccharides,
wherein the oral disease is any one selected from the group consisting of dental caries, gingivitis, periodontitis, oral mucous ulcers, halitosis, and xerostomia.
6 . The oral hygiene composition of claim 5 , wherein the agarooligosaccharides are obtained from an acid hydrolysate of agarose.
7 . The oral hygiene composition of claim 5 , wherein the agarooligosaccharides are a mixture of agarobiose, agarotetraose, agarohexaose, and agarooctaose.
8 . The oral hygiene composition of claim 5 , wherein the agarobiose is obtained by separating and purifying an acid hydrolysate of agarose through gel permeation chromatography.
9 . A food composition for preventing or alleviating an oral disease, comprising one or more selected from the group consisting of agarobiose and agarooligosaccharides,
wherein the oral disease is any one selected from the group consisting of dental caries, gingivitis, periodontitis, oral mucous ulcers, halitosis, and xerostomia.
10 . The food composition of claim 9 , wherein the agarooligosaccharides are obtained from an acid hydrolysate of agarose.
11 . The food composition of claim 9 , wherein the agarooligosaccharides are a mixture of agarobiose, agarotetraose, agarohexaose, and agarooctaose.
12 . The food composition of claim 9 , wherein the agarobiose is obtained by separating and purifying an acid hydrolysate of agarose through gel permeation chromatography.Join the waitlist — get patent alerts
Track US2020078383A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.